CN1706802A - Prepn process of 2-ary lactate, naprosyn and ibuprofen - Google Patents

Prepn process of 2-ary lactate, naprosyn and ibuprofen Download PDF

Info

Publication number
CN1706802A
CN1706802A CN 200510026269 CN200510026269A CN1706802A CN 1706802 A CN1706802 A CN 1706802A CN 200510026269 CN200510026269 CN 200510026269 CN 200510026269 A CN200510026269 A CN 200510026269A CN 1706802 A CN1706802 A CN 1706802A
Authority
CN
China
Prior art keywords
reaction
lactate
ary
degree
alkali
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510026269
Other languages
Chinese (zh)
Other versions
CN1309700C (en
Inventor
姜标
司玉贵
陈君
刘家峰
李凡
李金华
秦叶军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Bailun Fine Chemicals Co ltd
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Zhuhai Bailun Fine Chemicals Co ltd
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai Bailun Fine Chemicals Co ltd, Shanghai Institute of Organic Chemistry of CAS filed Critical Zhuhai Bailun Fine Chemicals Co ltd
Priority to CNB2005100262698A priority Critical patent/CN1309700C/en
Publication of CN1706802A publication Critical patent/CN1706802A/en
Application granted granted Critical
Publication of CN1309700C publication Critical patent/CN1309700C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides convenient and cheap process of synthesizing 2-aryl lactate and its derivatives. Under the action of Lewis acid and in the condition with or without alkali, the rich-electron place of arene and acetonate produce Friedel-Crafts reaction directly to prepare 2-aryl lactate in high yield. The said process has mild condition and easy-to-obtain material and is suitable for industrial production. The product may be further dewatered, reduced and saponified to prepare the derivatives naprosyn, ibuprofen, etc.

Description

A kind of method for preparing 2-ary lactate and Naproxen Base, Ibuprofen BP/EP
Technical field:
The present invention relates to a kind of preparation method of 2-ary lactate and derivative thereof.
Background technology:
The 2-ary lactate is a kind of important synthesis intermediates, such as being used for the synthetic of the analgesic widely anti-inflammation and analgesic drugs 2-of class arylpropionic acid, and as Naproxen Base, Ibuprofen BP/EP etc.The method of existing Synthetic 2-ary lactate mainly contains: and the methylating of 2-aryl-2-glycolic acid esters (J.Org.Chem.1977,42,2948-2950); Aryl ketones acid esters and the reaction of methyl Grignard reagent (Tetrahedron, 1987,4979-4988); The Grignard reagent of halogenated aryl hydrocarbon and pyruvate reaction (Tetrahedron, 1996,8257-8262); Phenol under the titanium tetrachloride effect with pyruvate reaction (Synthesis, 1984,760-763) preparation. the harsh and raw material costliness of first three kind condition of aforesaid method, the 4th kind of method only is confined to phenolic compound.
Summary of the invention:
The problem to be solved in the present invention provides a kind of convenience and the Synthetic 2-ary lactate of cheapness and the method for derivative thereof.
Method of the present invention is under a kind of Lewis acid effect, adding or do not adding under a kind of condition of alkali, the electron rich position of aromatic hydrocarbons directly and pyruvate carry out Friedel-Crafts reaction, the preparation 2-ary lactate of high yield.This method mild condition, raw material cheapness that is easy to get is suitable for industrialization.
The invention provides a kind of method of the 2-of being prepared as follows ary lactate:
Figure A20051002626900051
Wherein Ar is the aryl that contains electron-donating group,
The described aryl that contains electron-donating group can be the aryl or the heteroaryl of electron donating group-substituted.Described aryl can be phenyl, naphthyl, also can for nitrogenous, oxygen, sulphur five to seven membered heterocyclic or its benzo ring, be single replacements, two replacements, trisubstituted furans, thiophene or indoles (substituting group can be silica-based, the p-toluenesulfonyl of the alkyl replacement of alkyl, the amino of the alkoxyl group of one to six carbon, one to six carbon, one to six carbon) as ArH; That described electron-donating group is recommended as that the alkyl of alkyl, the amino of the alkoxyl group of one to six carbon, one to six carbon, one to six carbon replaces is silica-based, p-toluenesulfonyl etc.; The aryl of described electron donating group-substituted comprises the aryl of one or more electron donating group-substituted.Described heteroaryl be nitrogenous, oxygen, sulphur five to seven membered heterocyclic or its benzo ring, as pyrroles, furans, thiophene, indoles etc.
R is the alkyl of one to six carbon.
Method of the present invention comprises the steps (1) or step (1) and (2):
(1) under a kind of Lewis acid effect, adds or do not add under the condition of alkali, the direct and pyruvate in the electron rich position of aromatic hydrocarbons ArH
Figure A20051002626900061
Carry out Friedel-Crafts reaction and be prepared as follows the 2-ary lactate of structure:
Figure A20051002626900062
Wherein Ar, R are as previously mentioned;
(2) gained 2-ary lactate restores and synthetic Naproxen Base of saponification and Ibuprofen BP/EP through routine reaction elimination dehydration when Ar is 2-methoxynaphthalene or second butylbenzene.
The concrete recommendation comprises the steps:
1. alkali is added in the organic solvent, add the pyruvate of electron rich aromatic hydrocarbons (Ar-H) and following structure again;
Figure A20051002626900063
Ar and R are as previously mentioned;
2. then this system is cooled to subzero 25 and spends zero degree, begin to add Lewis acid under stirring;
3. spend to reaction between 50 degree subzero 25, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
4. the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate.
Above-mentioned reinforced sequencing also can change, as earlier electron rich aromatic hydrocarbons (Ar-H) and Lewis acid adding reaction system being added pyruvate again.
When adding alkali, can be organic bases in the aforesaid method, as triethylamine, diethylamine, pyridine, piperidines, diisopropylethylamine is recommended as triethylamine; Also can be mineral alkali, as metal carbonate (salt of wormwood, yellow soda ash etc.), metal hydroxides (sodium hydroxide, potassium hydroxide etc.), metal oxide (calcium oxide, magnesium oxide, zinc oxide, aluminum oxide, titanium oxide, barium oxide etc.) is recommended as aluminum oxide.
Organic solvent is recommended as tetrahydrofuran (THF) in the aforesaid method, methylene dichloride, and oil of mirbane, chlorobenzene, ethylene dichloride, methyl tertiary butyl ether, Nitromethane 99Min., benzene, tetracol phenixin, perhaps the mixture of above solvent is recommended as ethylene dichloride.
Lewis acid is recommended as aluminum chloride in the aforesaid method, zinc chloride, iron(ic) chloride, titanium tetrachloride, nickelous chloride, tin tetrachloride, tindichloride, zirconium tetrachloride, boron trifluoride diethyl etherate, trimethylchlorosilane, trifluoromethanesulfonic acid zinc, copper trifluoromethanesulfcomposite, Bismuth triflate is recommended as titanium tetrachloride.
In the aforesaid method between each reactant the ratio of amount of substance be recommended as:
Aromatic hydrocarbons: pyruvate: alkali: Lewis acid=1.0: 1.0~1.5: 1.0~3.0: 0.5~2.5 recommendering folder invented technology are used for compound synthetic of following structure:
Reaction formula is:
Figure A20051002626900072
Recommendation comprises the steps:
1. with in phenyl ethyl ether and pyruvate and the alkali adding organic solvent
2. then this system is cooled to subzero 50 and spends zero degree, begin to add Lewis acid under stirring;
3. spend to reaction between 5 degree subzero 50, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
4. the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate.
The recommendering folder invented technology is used for compound synthetic of following structure:
Figure A20051002626900081
Reaction formula is:
Comprise the steps:
1. with in 2-methoxynaphthalene and pyruvate and the alkali adding organic solvent
2. then this system is cooled to subzero 50 and spends zero degree, begin to add Lewis acid under stirring;
3. spend to reaction between 5 degree subzero 50, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
4. the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate
The products obtained therefrom ary lactate is Naproxen Base (dehydration reduction saponification is popular response) through dehydration reduction saponification:
The recommendering folder invented technology is used for compound synthetic of following structure:
Reaction formula is:
Figure A20051002626900091
Comprise the steps:
1. with in isobutyl-benzene and pyruvate and the alkali adding organic solvent
2. then this system is cooled to subzero 50 and spends zero degree, begin to add Lewis acid under stirring;
3. spend to reaction between 5 degree subzero 50, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
4. the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate
The products obtained therefrom ary lactate is Ibuprofen BP/EP (dehydration reduction saponification is popular response) through dehydration reduction saponification:
Embodiment
Following examples help to understand this patent but this patent protection domain is not limited to this.
Embodiment 1
40 gram phenyl ethyl ethers and 40 gram Pyruvic Acid Ethyl esters are added in 400 milliliters of methylene dichloride, add 31 gram aluminum oxide again, then this system is cooled to subzero 45 degree, begin to add titanium tetrachloride, keep under the zero temperature 45, under this temperature, react then to subzero 20 degree.Till gas-chromatography tracking reaction raw materials no longer reduces.Spend to reaction between 5 degree subzero 10, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction.The concentrated underpressure distillation of extraction liquid removes solvent and gets product ary lactate 43 grams, yield 55%.
The order of addition(of ingredients) of the described embodiment of following table is with embodiment 1 or earlier electron rich aromatic hydrocarbons (Ar-H) and Lewis acid adding reaction system are added pyruvate again.
Embodiment Raw material Lewis acid Alkali Temperature of reaction Solvent Yield
??2 Phenyl ethyl ether (1 mole) Pyruvic Acid Ethyl ester (1.2 moles) Tin tetrachloride (1.2 moles) Triethylamine (2.0 moles) ??-25 Toluene ??56
??3 Methyl-phenoxide (1 mole) Pyruvic Acid Ethyl ester (1.0 moles) Trifluoromethanesulfonic acid zinc (1.1 moles) Sodium hydroxide (2.0 moles) ??-30 Chlorobenzene ??71
??4 2 one naphthol methyl ethers (1 mole) Pyruvic Acid Methyl ester (1.5 moles) Titanium tetrachloride (0.8 mole) Aluminum oxide (1.5 moles) ??-5 Oil of mirbane ??60
??5 Isobuytel Benzene (1 mole) Pyruvic Acid Ethyl ester (1.1 moles) Tin tetrachloride (0.5 mole) Aluminum oxide (1.1 moles) ??-15 Ethylene dichloride ??53
??6 N one p-toluenesulfonyl indoles (1 mole) Pyruvic Acid Ethyl ester (1.2 moles) Aluminum chloride (0.9 mole) Aluminum oxide (1.1 moles) ??-25 Tetrahydrofuran (THF) ??89
??7 Thiophene (1 mole) Pyruvic Acid Ethyl ester (1.1 moles) Titanium tetrachloride (1.1 moles) Aluminum oxide (1.2 moles) ??-30 Benzene ??42
??8 Furans (1 mole) Pyruvic Acid Ethyl ester (1.1 moles) Tin tetrachloride (0.5 mole) Aluminum oxide (1.2 moles) ??-30 Benzene ??31
??9 Veratrole (1 mole) Pyruvic Acid Methyl ester (1.5 moles) Tin tetrachloride (0.6 mole) Pyridine (3.0 moles) ??-40 Benzene ??78
??10 P-dimethyoxy benzene (1 mole) Pyruvic Acid Methyl ester (1.5 moles) Iron(ic) chloride (2.5 moles) Yellow soda ash (1.0 moles) ??-45 Stupid ??82
??11 To dimethoxy Pyruvic Acid Methyl ester Iron(ic) chloride Do not add alkali ??-45 Benzene ??35
Base benzene (1 mole) (1.5 moles) (2.5 moles)
The compound characterization data:
Figure A20051002626900111
FTIR(neat):3523,2983,1721,1245cm -11H?NMR(CDCl 3,300MHz)δ=7.45(d,J=9.0Hz,2H),6.87(d,J=8.7Hz,2H),4.02(q,J=7.0Hz,2H),3.76(s,3H),3.72(s,1H),1.76(s,3H),1.41(t,J=7.0Hz,3H); 13C?NMR(CDCl 3,75MHz)δ=176.2,158.4,134.5,126.3,113.9,75.3,63.2,53.0,26.5,14.7;MS(EI)m/e?224(M+,5.9),165(100),43(36.9);Anal.Calcd?for?C 12H 16O 4:C,64.27;H,7.19.Found:C,64.11;H,711
FTIR(neat):3506,2983,1728,1247cm -11H?NMR(CDCl 3,300MHz)δ=7.46(d,J=9.0Hz,2H),6.87(d,J=8.7Hz,2H),4.25(q,J=7.1Hz,2H),4.02(q,J=7.0Hz,2H),3.77(s,3H),3.72(s,1H),1.75(s,3H),1.41(t,J=7.0Hz,3H),1.27(t,J=7.1Hz,3H); 13C?NMR(CDCl 3,75MHz)δ=175.6,158.3,134.7,126.3,113.9,75.1,63.2,62.0,26.5,14.6,13.9;MS(EI)m/e?238(M+,3.5),165(100),43(59.7);Anal.Calcd?forC 13H 18O 4:C,65.53;H,7.61.Found:C,65.59;H,7.66.
FTIR(neat):3516,2959,1729,1255cm -11H?NMR(CDCl 3,300MHz)δ=7.45(d,J=8.8Hz,2H),6.87(d,J=8.6Hz,2H),3.87(s,3H),3.78(s,3H),3.75(s,3H),1.76(s,3H); 13C?NMR(CDCl 3,75MHz)δ=176.2,159.0,134.7,126.4,113.5,75.3,55.1,53.1,26.6;MS(EI)m/e?210(M+,2.7),151(70.6),43(100);Anal.Calcd?for?C 11H 14O 4:C,62.85;H,6.71.Found:C,62.80;H,6.52.
FTIR(neat):3502,2954,1735,1261cm -11H?NMR(CDCl 3,300MHz)δ=7.06(d,J=2.2Hz,1H),7.02(d,J=2.0Hz,1H),6.78(d,J=2.3Hz,1H),3.85(s,1H),3.83(s,3H),3.81(s,3H),3.71(s,3H),1.72(s,3H); 13C?NMR(CDCl 3,75MHz)δ=176.0,148.5,148.4,135.2,117.4,110.6,108.4,75.4,55.7,53.1,26.6;MS(EI)m/e?240(M+,37.6),223(96.9),181(100),43(92.2);Anal.Calcd?for?C 12H 16O 5:C,59.99;H,6.71.Found:C,60.02;H,6.82.
Figure A20051002626900122
FTIR(neat):3501,2957,1743,1232cm -11H?NMR(CDCl 3,300MHz)δ=7.01(s,1H),6.78(s,2H),4.07(s,1H),3.73(s,3H),3.66(s,3H),3.58(s,3H),1.70(s,3H); 13C?NMR(CDCl 3,75MHz)δ=176.1,153.5,150.6,132.2,113.2,112.7,111.9,74.0,55.9,55.6,52.5,24.1;MS(EI)m/e?240(M+,13.2),223(2.9),181(99.5),43(100);Anal.Calcd?for?C 12H 16O 5:C,59.99;H,6.71.Found:C,59.74;H,6.61.
Figure A20051002626900131
FTIR(KBr):3511,2959,1735,1372cm -11H?NMR(CDCl 3,300MHz)δ=7.95(d,J=8.6Hz,1H),7.76(d,J=8.2Hz,2H),7.70(d,J=8.0Hz,1H),7.65(s,1H),7.32-7.18(m,4H),3.93(s,1H),3.73(s,3H),2.31(s,3H),1.87(s,3H); 13CNMR(CDCl 3,75MHz)δ=175.7,145.1,135.4,134.9,129.9,128.1,126.9,124.7,124.1,123.7,123.3,121.2,113.5,72.6,53.4,25.9,21.5;MS(EI)m/e?373(M+,6.5),355(10.0),314(93.9),155(38.7),91(100);Anal.Calcd?for?C 19H 19NO 5S:C,61.11;H,5.13;N,3.75.Found:C,61.13;H,5.14;N,3.57.
FTIR(neat):3524,2959,1733,1259cm -11H?NMR(CDCl 3,300MHz)δ=7.76(dd,J=8.8?and?0.8Hz,1H),7.47(dd,J=8.3?and?0.8Hz,1H),7.19(s,1H),7.15-7.10(m,2H),3.82(s,1H),3.74(s,3H),1.91(s,3H),0.92(s,9H),0.59(s,6H); 13CNMR(CDCl 3,75MHz)δ=176.4,141.8,128.3,128.0,121.3,120.1,119.9,119.7,113.9,72.9,52.8,26.1,25.9,19.2,-4.1;MS(EI)m/e?333(M+,10.5),217(100);Anal.Calcd?for?C 18H 27NO 3Si:C,64.83;H,8.16;N,4.20.Found:C,64.63;H,8.14;N,4.37.
Figure A20051002626900141
FTIR(neat):3534,2959,1750cm -11H?NMR(CDCl 3,300MHz)δ=6.42(d,J=4.8Hz,1H),6.30(d,J=8.3,1H),5.90(d,J=4.8Hz,1H),5.0(br,1H),3.82(s,1H),3.74(s,3H),1.91(s,3H); 13C?NMR(CDCl 3,75MHz)δ=168.7,118.8,117.3,116.1,114.0,78.9,52.8,25.4;MS(EI)m/e?169(M+,100);Anal.Calcd?forC 8H 11NO 3:C,56.80;H,6.55;N,8.28.Found:C,56.63;H,6.34;N,8.37.

Claims (10)

1. the method for a Synthetic 2-ary lactate and Naproxen Base and Ibuprofen BP/EP is characterized in that comprising the steps (1) or step (1) and (2):
(1) under a kind of Lewis acid effect, adds or do not add under the condition of alkali, the direct and pyruvate in the electron rich position of aromatic hydrocarbons ArH
Figure A2005100262690002C1
Carry out Friedel-Crafts reaction and be prepared as follows the 2-ary lactate of structure:
Figure A2005100262690002C2
Wherein Ar is the aryl that contains electron-donating group, and R is the alkyl that contains one to six carbon;
(2) gained 2-ary lactate restores and synthetic Naproxen Base of saponification and Ibuprofen BP/EP through eliminating dehydration when Ar is 2-methoxynaphthalene or second butylbenzene.
2. the method for claim 1, it is characterized in that the described aryl Ar that contains electron-donating group is the phenyl of electron donating group-substituted, the naphthyl of electron donating group-substituted, nitrogenous, the oxygen of electron donating group-substituted, sulphur five to seven membered heterocyclic or its benzo ring, or heteroaryl.
3. the method for claim 1 is characterized in that described electron-donating group is silica-based, the p-toluenesulfonyl that the alkyl of alkyl, the amino of the alkoxyl group of one to six carbon, one to six carbon, one to six carbon replaces.
4. the method for claim 1 is characterized in that described step (1) comprising:
A. alkali is added in the organic solvent, add the pyruvate of electron rich aromatic hydrocarbons (Ar-H) and following structure again; Ar and R are according to claim 1;
B. then this system is cooled to subzero 25 and spends zero degree, begin to add Lewis acid under stirring; Perhaps earlier electron rich aromatic hydrocarbons (Ar-H) and Lewis acid adding reaction system are added pyruvate again;
C. spend to reaction between 50 degree subzero 25, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
D. the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate.
5. as claim 1 or 4 described methods, it is characterized in that described Lewis acid is: aluminum chloride, zinc chloride, iron(ic) chloride, titanium tetrachloride, nickelous chloride, tin tetrachloride, zirconium tetrachloride, tindichloride, boron trifluoride diethyl etherate, trimethylchlorosilane, trifluoromethanesulfonic acid zinc, copper trifluoromethanesulfcomposite, Bismuth triflate.Described alkali is triethylamine, diethylamine, pyridine, piperidines, diisopropylethylamine, alkali-metal carbonate, alkali-metal oxyhydroxide, metal oxide.
6. as claim 1 or 4 described methods, it is characterized in that described being reflected in the organic solvent carry out, described organic solvent is a tetrahydrofuran (THF), methylene dichloride, oil of mirbane, chlorobenzene, ethylene dichloride, methyl tertiary butyl ether, Nitromethane 99Min., benzene, tetracol phenixin, the perhaps mixture of above solvent.
7. as claim 1 or 4 described methods, it is characterized in that the ratio of amount of substance between the described reactant is: aromatic hydrocarbons: pyruvate: alkali: Lewis acid=1.0: 1.0~1.5: 1.0~3.0: 0.5~2.5.
8. the method for claim 1 is characterized in that being used for compound synthetic of following structure:
Figure A2005100262690003C1
Comprise the steps:
(1). in phenyl ethyl ether and pyruvate and alkali adding organic solvent
(2). then this system is cooled to subzero 50 and spends zero degree, begin to add Lewis acid under stirring;
(3). spend to reaction between 5 degree subzero 50, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
(4). the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate.
9. the method for claim 1 is characterized in that being used for compound synthetic of following structure:
Comprise the steps:
(1). in 2-methoxynaphthalene and pyruvate and alkali adding organic solvent
(2). then this system is cooled to subzero 50 and spends zero degree, begin to add Lewis acid under stirring;
(3). spend to reaction between 5 degree subzero 50, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
(4). the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate
(5) the products obtained therefrom ary lactate is Naproxen Base through routine reaction dehydration reduction saponification.
10. the method for claim 1 is characterized in that being used for compound synthetic of following structure:
Comprise the steps:
(1). in isobutyl-benzene and pyruvate and alkali adding organic solvent
(2). then this system is cooled to subzero 50 and spends zero degree, begin to add Lewis acid under stirring;
(3). spend to reaction between 5 degree subzero 50, after reacting completely reaction mixture is added in the water of the 0-5 degree that stirs the cancellation reaction;
(4). the concentrated underpressure distillation of extraction liquid removes solvent and gets the product ary lactate;
(5). the products obtained therefrom ary lactate is Ibuprofen BP/EP through routine reaction dehydration reduction saponification.
CNB2005100262698A 2005-05-27 2005-05-27 Prepn process of 2-ary lactate, naprosyn and ibuprofen Expired - Fee Related CN1309700C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100262698A CN1309700C (en) 2005-05-27 2005-05-27 Prepn process of 2-ary lactate, naprosyn and ibuprofen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100262698A CN1309700C (en) 2005-05-27 2005-05-27 Prepn process of 2-ary lactate, naprosyn and ibuprofen

Publications (2)

Publication Number Publication Date
CN1706802A true CN1706802A (en) 2005-12-14
CN1309700C CN1309700C (en) 2007-04-11

Family

ID=35580938

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100262698A Expired - Fee Related CN1309700C (en) 2005-05-27 2005-05-27 Prepn process of 2-ary lactate, naprosyn and ibuprofen

Country Status (1)

Country Link
CN (1) CN1309700C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102516062A (en) * 2011-12-02 2012-06-27 青岛科技大学 Hydrolysis outer circulation heat exchange process and device for friedel-crafts reaction liquid for synthesis of ibuprofen
CN115650863A (en) * 2022-09-05 2023-01-31 上海博纳赛恩医药研发有限公司 Method for preparing venlafaxine hydrochloride
CN116730939A (en) * 2022-12-12 2023-09-12 如东众意化工有限公司 Preparation method of famoxadone characteristic impurities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329396C (en) * 1987-03-20 1994-05-10 Varadaraj Elango Method for producing ibuprofen
CA1338673C (en) * 1988-04-15 1996-10-22 Graham N. Mott Catalyst recycle in the carbonylation of isobutylphenylethanol to ibuprofen
CN1034661C (en) * 1992-04-08 1997-04-23 中国科学院兰州化学物理研究所 Method of synthesis of dl-Naproxen
JPH08134017A (en) * 1994-11-11 1996-05-28 Mitsubishi Gas Chem Co Inc Production of alpha-alkoxycarboxylic acid ester

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102516062A (en) * 2011-12-02 2012-06-27 青岛科技大学 Hydrolysis outer circulation heat exchange process and device for friedel-crafts reaction liquid for synthesis of ibuprofen
CN102516062B (en) * 2011-12-02 2014-04-16 青岛科技大学 Hydrolysis outer circulation heat exchange process and device for friedel-crafts reaction liquid for synthesis of ibuprofen
CN115650863A (en) * 2022-09-05 2023-01-31 上海博纳赛恩医药研发有限公司 Method for preparing venlafaxine hydrochloride
CN116730939A (en) * 2022-12-12 2023-09-12 如东众意化工有限公司 Preparation method of famoxadone characteristic impurities

Also Published As

Publication number Publication date
CN1309700C (en) 2007-04-11

Similar Documents

Publication Publication Date Title
CN1163452C (en) Process for preparing nitrobiphenylene
CN101058557A (en) Method of preparing polyhydroxy annular nitrone
CN1805926A (en) Process for the preparation of trans-isomers of diphenylazetidinone derivatives
CN1944406A (en) Indole heterocyclic compounds and intermediate, and synthetic method
CN1309700C (en) Prepn process of 2-ary lactate, naprosyn and ibuprofen
CN102382001B (en) Synthesis method for ortho amino aromatic formic acid aryl ester derivatives
CN113563372B (en) Alkenyl borate synthesis method
CN104356109A (en) Preparation method of 2-(( 4R,6S)-6-bromoethyl-2,2-dimethyl-1,3-dioxyhexacyclo-4-yl)acetate
CN1762926A (en) Process for preparing cyclic ketones
CN108467376A (en) A kind of synthetic method of dibenzofuran derivative
CN115010600B (en) Method for synthesizing polyfluoroaryl carboxylic acid compound based on aryl fluorocarbon bond carboxylation reaction
CN1244531C (en) Process for producing 5-bromo-2-fluorobenzoic boric acid
Merino et al. Stereocontrolled Approach to Phenyl Cyclitols from (SR)-[(p-Tolylsulfinyl) methyl]-p-quinol
CN107266317A (en) A kind of chiral aryl allyl ether series compound and its synthetic method
CN108250112B (en) A kind of 1- alkyl -1- arylthio -2- (1H)-naphthalene ketone derivant and preparation method thereof
CN1371380A (en) Process for preparation of cephem compounds
CN1665824A (en) Substituted aryl boronic acids, their preparation and their precursors
CN1093542C (en) Process for preparing (1-trifluoromethyl) ene boric acid and its application
CN112521278B (en) Method for preparing carboxylic ester compound
CN1733694A (en) The method for preparing precursor of cycloprothrin
CN115784847B (en) New application of triphenylphosphine diiodide as reaction promoter
CN1923806A (en) Preparation method of optically active 4-phenylthio-2-butanol
CN1118161A (en) Process for the preparation of ortho-hydroxy substituted aromatic nitriles via dehydration of the corresponding aldoximes
CN1166657C (en) Dihydrofuran heterocyclic compounds and synthesis process thereof
CN1261410C (en) Synthesis of 4-substrated aryl-1-benzenesulfonyl-3-butylene-2-one

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070411

Termination date: 20180527

CF01 Termination of patent right due to non-payment of annual fee